Weill Institute for Neurosciences, Movement Disorder and Neuromodulation Center, University of California, San Francisco, 1635 Divisadero St., Suite 520, San Francisco, CA, 94115, USA.
Neurotherapeutics. 2020 Oct;17(4):1622-1644. doi: 10.1007/s13311-020-00944-0. Epub 2020 Oct 23.
Dystonia is a complex disorder with numerous presentations occurring in isolation or in combination with other neurologic symptoms. Its treatment has been significantly improved with the advent of botulinum toxin and deep brain stimulation in recent years, though additional investigation is needed to further refine these interventions. Medications are of critical importance in forms of dopa-responsive dystonia but can be beneficial in other forms of dystonia as well. Many different rehabilitative paradigms have been studied with variable benefit. There is growing interest in noninvasive stimulation as a potential treatment, but with limited long-term benefit shown to date, and additional research is needed. This article reviews existing evidence for treatments from each of these categories. To date, there are many examples of incomplete response to available treatments, and improved therapies are needed.
肌张力障碍是一种复杂的疾病,有多种表现形式,可单独出现或与其他神经症状同时出现。近年来,随着肉毒杆菌毒素和深部脑刺激技术的出现,其治疗方法得到了显著改善,但仍需要进一步研究以进一步完善这些干预措施。药物在多巴胺反应性肌张力障碍等形式中至关重要,但在其他形式的肌张力障碍中也可能有益。已经研究了许多不同的康复模式,但效果各不相同。人们对非侵入性刺激作为一种潜在治疗方法的兴趣日益增加,但迄今为止显示出的长期益处有限,还需要进一步的研究。本文综述了来自这些类别的每种治疗方法的现有证据。迄今为止,有许多对现有治疗方法反应不完全的例子,因此需要改进治疗方法。